The central government has allocated an additional 2,12,540 vials of Amphotericin-B to treat black fungus.
As per the latest reports, three confirmed cases of Avascular Necrosis (AVN) or death of bone tissues, after contracting COVID-19, have been reported in Mumbai. After the outbreak of mucormycosis or black fungus, experts are labelling AVN as the next debilitating condition among post-COVID patients.
It is expected that in the upcoming months, more cases of AVN can surface. Further, to treat the rising cases of black fungus in the country, the central government has distributed another 2,12,540 vials of Amphotericin-B among states and UTs.
MRI needed to confirm AVN
Three patients under the age of 40 have been recently diagnosed with AVN, months after being treated for COVID-19, in a hospital at Mahim, Mumbai. These patients had developed pain in their femur bone and since they were medical professionals, they timely caught onto the symptoms, read reports. It has been noted that for a confirmed diagnosis, patients need to get a Magnetic Resonance Imaging (MRI) of the said area.
Further, it has come to the attention of doctors that the common factor between AVN and mucormycosis is the use of steroids, which is the only drug proven to help infected patients. On Saturday, the Medical Director of Hinduja Hospital, Dr. Sanjay Agarwala's research paper titled- 'Avascular necrosis as a part of long Covid-19' was published in BMJ Case Studies. This paper states that "large-scale use of life-saving corticosteroids" in COVID-19 cases will result in a "resurgence of AVN cases".
Another 2 lakh vials of Amphotericin distributed
The central government has allocated an additional 2,12,540 vials of Amphotericin-B to states, Union Territories (UTs) and central institutions. Thereby, the current tally of vials given across India stands at 10 lakh and this has been done in response to the alarming rise in the number of cases of mucormycosis documented recently by doctors.
-With inputs from PTI